Is Buying PharmaCan Capital Corp Here a Winning Strategy?

 Is Buying PharmaCan Capital Corp Here a Winning Strategy?

The stock of PharmaCan Capital Corp (CVE:MJN) is a huge mover today! About 298,085 shares traded hands. PharmaCan Capital Corp (CVE:MJN) has risen 6.00% since October 8, 2016 and is uptrending. It has outperformed by 4.04% the S&P500.
The move comes after 9 months positive chart setup for the $133.98M company. It was reported on Nov, 7 by Barchart.com. We have $1.80 PT which if reached, will make CVE:MJN worth $79.05M more.

More notable recent PharmaCan Capital Corp (CVE:MJN) news were published by: Marketwatch.com which released: “Moshe Azogui Announces Increase in Equity Interest in PharmaCan Capital Corp.” on June 08, 2016, also Midasletter.com with their article: “PharmaCan Capital Corp (TSX.V:MJN) CEO Paul Rosen Interview and Podcast” published on February 20, 2015, Marketwired.com published: “PharmaCan Acquires Peace Naturals Project Inc.” on September 06, 2016. More interesting news about PharmaCan Capital Corp (CVE:MJN) were released by: Marketwired.com and their article: “PharmaCan Capital Corp. Announces Approval of Increased Production Expansion …” published on April 01, 2015 as well as Marketwired.com‘s news article titled: “PharmaCan Capital Corp. to Open Toronto Stock Exchange” with publication date: January 13, 2015.

PharmaCan Capital Corp., formerly Searchtech Ventures Inc., is a merchant bank, which is focused on investing in Canada’s medical marijuana industry. The company has a market cap of $133.98 million. The Firm is engaged in the business of investing in companies either licensed or seeking a license to produce medical marijuana. It currently has negative earnings. The Firm operates through two divisions: Investing Segment and Operating Segment.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Tags: , ,

Related posts

Leave a Comment